Daniel Myran
Dr. Daniel Myran is a family, public health, and preventative medicine physician and researcher at the University of Ottawa in Ontario. He is known for his research into the real-world effects of psychedelics, particularly focusing on the risks associated with adverse reactions to hallucinogens, as highlighted in a recent study he led that found a significant increase in mortality risk following bad psychedelic trips.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 8.00 | 0.09% | +0% | 38,005,238 | 33,544 | $1,700,000 | 1,500$ |
| Totals | 1 | 38,005,238 | 33,544 | $1,700,000 | 1,500$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Daniel Myran is a family physician and ICES scientist who co-authored the study on ADHD prescriptions.
8
Brazil:
Daniel Myran is a researcher at the Bruyère Health Research Institute in Ottawa who studies cannabis-related health issues.
6
United States:
Dr. Daniel Myran is a coauthor of the study linking cannabis use to an increased risk of dementia.
7
Canada:
Daniel Myran is the study’s senior author and a family physician at Ottawa Hospital.
8
United States:
Dr. Daniel Myran is the lead study author who researched the risks associated with bad psychedelic trips.
7